| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 11th June 2018 | Yaron Adler | 37,662 | Conversion of derivative | $0.00 |
Orgenesis
Orgenesis, Inc. engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. The company was founded on June 5, 2008 by Sarah Ferber and is headquartered in Germantown, MD.
Ticker: ORGS
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1460602
Employees: 309
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Revenue From Related Parties of $493 Th for the period Jan 2020 to Mar 2020 in the context of all up
